Newswise — April 26, 2021 – Wolters Kluwer, Health announced today the addition of two fully open access journals to the Lippincott® portfolio as part of a shared mission with Shandong University to expand the reach of healthcare discoveries globally with the publication of Emergency and Critical Care Medicine and Current Urology. The new open access titles publish original research in their respective medical specialties.

“We are always looking to increase access to quality scientific research and the addition of these open access journals to our portfolio supports that mission,” said Jennifer Brogan, Vice President, Journal Publishing & Society Services at Wolters Kluwer, Health Learning, Research & Practice. “We are delighted to build upon our relationship with Shandong University with these titles and to help them deliver impactful clinical research to healthcare professionals worldwide.”

Emergency and Critical Care Medicine is dedicated to improving the quality of care by publishing basic and clinical cutting-edge findings in emergency, critical care and related medical specialties. Research areas covered in the journal include cardiopulmonary resuscitation, acute cardiovascular diseases, stroke, shock, acute respiratory failure, infection, trauma, out-of-hospital emergency medical services, disaster management, toxicology, organ dysfunction, artificial intelligence, and life-supporting devices. The first issue of Emergency and Critical Care Medicine will be available in September 2021. Manuscripts may be submitted at

First launched in 2007, Current Urology provides practical, timely, and state-of-the-art contributions on clinical research and experience in urology. The journal encompasses all aspects of basic urological research, clinical diagnosis, surgical and medical oncology, radiology, pathology, urolithiasis, andrology, reconstruction surgery, pediatric urology, female urology and urodynamics, erectile dysfunction, infertility, urinary infections and inflammations, endourology, and transplantation. The March 2021 issue was the first published by Wolters Kluwer. Manuscripts may be submitted at

“We look forward to working with Wolters Kluwer in publishing these international and peer-reviewed journals. Their strength in these two fields will enable us to deliver important research to a global audience,” said Bin Chen, President of Shandong University Scientific Journals Press.


About Shandong University

Shandong University, under the direct jurisdiction of the Ministry of Education, is a member university of China's Double-First Class initiative and a key comprehensive university with a long history, a variety of disciplines, strong academic strength, and distinctive characteristics, which has great influence both at home and abroad. For more than 100 years, Shandong University has been following the mission of “Nurture talents for the world, and seek prosperity for the nation." S​handong University is committed to excellence, and its financial mathematics, crystal materials, colloid and surface chemistry, micro-biology, underground engineering, cardiovascular functional recovery, reproductive medicine, and new drug manufacturing have all risen to the first-class level.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit, follow us on TwitterFacebookLinkedIn, and YouTube.